Literature DB >> 22955633

Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies.

Sanjeev Rajakulendran, Stuart Viegas, Jennifer Spillane, Robin S Howard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955633     DOI: 10.1007/s00415-012-6661-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  16 in total

1.  Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG.

Authors:  Y Hatanaka; S Hemmi; M B Morgan; M L Scheufele; G C Claussen; G I Wolfe; S J Oh
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

2.  Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus.

Authors:  Arunee Bhibhatbhan; Gregory Kline; Angela Vincent; Cory Toth
Journal:  Muscle Nerve       Date:  2007-08       Impact factor: 3.217

3.  Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.

Authors:  Bilal Saulat; Paul Maertens; William J Hamilton; Bassam A Bassam
Journal:  Neurology       Date:  2007-08-21       Impact factor: 9.910

4.  MuSK-antibody positive myasthenia gravis: questions from the clinic.

Authors:  Donald B Sanders; Vern C Juel
Journal:  J Neuroimmunol       Date:  2008-08-05       Impact factor: 3.478

5.  Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.

Authors:  Maria Isabel Leite; Philipp Ströbel; Margaret Jones; Kingsley Micklem; Regina Moritz; Ralf Gold; Erik H Niks; Sonia Berrih-Aknin; Francesco Scaravilli; Aurea Canelhas; Alexander Marx; John Newsom-Davis; Nick Willcox; Angela Vincent
Journal:  Ann Neurol       Date:  2005-03       Impact factor: 10.422

6.  Long-term immunologic effects of thymectomy in patients with myasthenia gravis.

Authors:  R Gerli; R Paganelli; A Cossarizza; C Muscat; G Piccolo; D Barbieri; S Mariotti; D Monti; O Bistoni; E Raiola; F M Venanzi; A Bertotto; C Franceschi
Journal:  J Allergy Clin Immunol       Date:  1999-05       Impact factor: 10.793

7.  Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.

Authors:  Mamatha Pasnoor; Gil I Wolfe; Sharon Nations; Jaya Trivedi; Richard J Barohn; Laura Herbelin; April McVey; Mazen Dimachkie; John Kissel; Ronan Walsh; Anthony Amato; Tahseen Mozaffar; Marcel Hungs; Luis Chui; Jonathan Goldstein; Steven Novella; Ted Burns; Lawrence Phillips; Gwendolyn Claussen; Angela Young; Tulio Bertorini; Shin Oh
Journal:  Muscle Nerve       Date:  2010-03       Impact factor: 3.217

8.  Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.

Authors:  Jordi Díaz-Manera; Ricard Rojas-García; Eduard Gallardo; Cándido Juárez; Alejandro Martínez-Domeño; Sergi Martínez-Ramírez; Josep Dalmau; Rafael Blesa; Isabel Illa
Journal:  Nat Clin Pract Neurol       Date:  2007-07

9.  Clinical aspects of MuSK antibody positive seronegative MG.

Authors:  D B Sanders; K El-Salem; J M Massey; J McConville; A Vincent
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

10.  Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy.

Authors:  Anna Kostera-Pruszczyk; Hubert Kwiecinski
Journal:  J Neurol       Date:  2009-06-23       Impact factor: 4.849

View more
  5 in total

Review 1.  Neuro-ophthalmology update.

Authors:  Konrad P Weber; Dominik Straumann
Journal:  J Neurol       Date:  2013-09-26       Impact factor: 4.849

Review 2.  Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Authors:  Michael H Rivner; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; Lin Mei
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

3.  Juvenile Generalized Myasthenia Gravis With AChR and MuSK Antibody Double Positivity: A Case Report With a Review of the Literature.

Authors:  XiuShan Ge; CuiJie Wei; Hui Dong; YueHua Zhang; XinHua Bao; Ye Wu; DanYu Song; HongJun Hao; Hui Xiong
Journal:  Front Pediatr       Date:  2022-05-11       Impact factor: 3.569

4.  Myasthenic Crisis Complicated with Myxedema, Positive for Both Anti-acetylcholine Receptor and Anti-muscle-specific Tyrosine Kinase Antibodies.

Authors:  Kazuhiro Horiuchi; Azusa Nagai; Masahiro Wakita; Shotaro Ito; Kei Takamura; Hideki Houzen
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

Review 5.  Complicating autoimmune diseases in myasthenia gravis: a review.

Authors:  Aliona Nacu; Jintana Bunpan Andersen; Vitalie Lisnic; Jone Furlund Owe; Nils Erik Gilhus
Journal:  Autoimmunity       Date:  2015-04-27       Impact factor: 2.815

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.